No summary available
Searching for Solutions
No summary available
No summary available
AAPP Outcomes Grant The application portal is OPEN. Deadline: Oct.
Every 2 years (on the even year), the Resident and New Practitioner Committee conducts a survey of program directors to establish emerging trends in psychiatric pharmacy residency programs.
Suicide Prevention starts with all of us. Together we can create communities where people feel seen, supported and connected. Learn more: samhsa.gov/mental-health/suicidal-behavior/prevention #SPM2026 #StrongerTogether #SupportMatters
Studying for the BCPP exam? Test your knowledge with our 150-question mock exam! #psychpharmacy #BCPP #AAPP #BPS #boardcertification
These free articles are intended to provide advice from experts for students, residents, and new practitioners.
Here you will find tools and resources for all AAPP Collegiate chapters - whether you are considering starting a chapter at your pharmacy school or are looking for information for established chapters.
No summary available
As the home association and voice of psychiatric pharmacy, the American Association of Psychiatric Pharmacists (AAPP) seeks to:
Calling all psychiatric pharmacist rising stars. Nominate yourself or others for the AAPP Early Practitioner Award designed to recognize future leaders within AAPP and Psychiatric Pharmacy. Nominations close 10/1/2026.
The American Association of Psychiatric Pharmacists (AAPP) is a professional association representing psychiatric pharmacists, residents and aspiring future psychiatric pharmacists (students). AAPP's members are specialized and highly trained in psychiatry, substance use disorders, psychopharmacology, and mitigation of psychosocial factors.
In TRBD, adjunctive IV ketamine was well tolerated and associated with significant antidepressant effects compared to midazolam.
No summary available
A summary of a recent Summit in Philadelphia of outpatient and inpatient service providers who specialize in the care of persons who use drugs to discuss medetomidine response readiness and building ongoing community readiness for potential destabilizing drug supply changes.
Learn all about Antipsychotic Long-Acting Injectable Pharmacology and Dosing in this module! This is one of six modules in our complimentary Psychotropic LAI Training Program. Register today and get access to the full program and LAI resources.
This paper will discuss intrinsic and extrinsic motivators of treatment, as well as patient nonadherence and disengagement from services, including the effects of perceived coercion, insight, and the therapeutic alliance.
Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health care. With an extensive knowledge of medication management, they are skilled at treating the whole patient. They strengthen the mental health team by working directly with patients, improving outcomes and saving lives.
No summary available
This 8.5 hour workshop will convene experts across sectors and disciplines to consider current research, discuss what is known and areas of uncertainty, methodological challenges, and gaps in current knowledge. Discussion will be organized around neural systems and types of digital technologies (e.g., gaming, social media, and passive media).
This webinar will review the key design and primary and secondary outcomes from NIDA Clinical Trials Network Study 0080. This landmark study randomized 140 pregnant adults with moderate-severe OUD across multiple collaborative care addiction and OB/GYN treatment programs. Participants were randomized to either extended-release buprenorphine or sublingual buprenorphine. Study treatment was provided through delivery and for 12 months post-partum.